New York cannabis industry enters 2026 with growth, uncertainty
As 2026 begins, New York’s cannabis industry sees growing demand, regulatory shifts and federal policy changes, even as operators face ongoing uncertainty.
Does marijuana rescheduling in the US make Canopy Growth a good buy in 2026?
The company has banked its hopes heavily on the prospects for marijuana legalization in the U.S., and it’s paid a steep price in recent years for doing so. Buying a stock based on the expectation that …
Legal Marijuana Access Faces An Existential Threat In 2026, And We Must Fight Back (Op-Ed)
These initiatives represent the first-ever large-scale coordinated attack on adult-use markets… This is not a drill. It is the moment to come together to defeat the prohibitionists.” By Adam Smith, …
Bemidji Planning Commission to review First City Cannabis, Julie Canty responds
On Dec. 18, the Bemidji Planning Commission motioned to table Julie Canty’s First City Cannabis project to allow legal counsel time to prepare findings to deny the project. It will be considered again …
CT announces $416K settlement with cannabis business in premature ‘gun-jumping’ in merger
The company, Crisp Cannabis, has three establishments in Bridgeport, East Hartford and Cromwell, the release said. The company that is seeking to acquire the businesses, Mohave CT LLC, also was …
CBD Stocks Creating Opportunities – Established (BCCI), (STG), (WEED), (ACRGF), (RLTR), (CBMJ), and Newcomer (VAPR) Lead the Charge
You would have to be living in isolation to have not picked up on the hottest marijuana derivative consumable and therapeutic center isolate CBD. CBD “Cannabidiol” is the non-psychoactive full spectrum derivative of the hemp and marijuana plant largely credited for the majority of the medical beneficial attributes associated with marijuana.
NYC Cannabis Retailer Launches Accelerator Program To Support Black-Owned Brands
The initial focus will be on Black-owned businesses operating in New York City.
FDA Head Says Marijuana Has ‘Benefit In Medical Conditions,’ But Trump Administration Also Concerned About ‘Side Effects’
The head of the Food and Drug Administration (FDA) says that while the Trump administration is taking the potential harms of marijuana use among youth “very seriously,” it’s also important to preserve …
New York Governor Signs Bills To Fix Marijuana Business Zoning Issue That Threatened Closure Of Over 150 Dispensaries
The governor of New York has signed legislation into law that revises zoning requirements for licensed marijuana businesses, granting more flexibility to retailers located within certain distances of …
How Jamie Pearson transformed from cannabis skeptic to international CEO
The former leader of publicly traded Bhang took a long route into the cannabis industry, via her father – and Cypress Hill.
Livermore Falls weighs possible moratorium on cannabis businesses
At its Jan. 6 meeting, the Select Board said current fees will stay the same while it reviews the cannabis ordinance.
Massachusetts marijuana industry reaches new high despite falling prices
Prices declined, but the number of sales continued to grow as cannabis sales in Massachusetts reached a new record high in 2025.
DOJ won’t delay cannabis rescheduling, GOP congressman says (Newsletter: January 12, 2026)
Trump admin ditches alcohol limit guidance as marijuana stays illegal; FL legalization bill; KY medical cannabis launch; MA sales total; TX hemp rules Subscribe to receive Marijuana Moment’s …
Sunderstorm Adds Lime To Its Growing Cannabis Brand Lineup
Sunderstorm’s acquisition of Lime adds fuel to a fast‑moving cannabis M&A cycle likely to reshape the industry in 2026.
High Hopes for Cannabis
In light of President Donald Trump’s December executive order urging for the reclassification of cannabis to a Schedule III narcotic, the nation likely …
Recent Comments